搜尋結果
2023
Pan, J. H. ,
Tsai, Y. S. ,
Cheng, Y. S. ,
Chang, C. M. ,
Wang, K. Y. &
Hu, F. W. ,
2023 11月 ,
於: International Journal of Urological Nursing. 17 ,
3 ,
p. 199-206 8 p. 研究成果: Article › 同行評審
Transurethral Resection of Prostate
100%
Urinary Catheters
99%
Catheters
21%
Postoperative Complications
15%
Urology
9%
Chou, L. P. ,
Hsu, C. W. ,
Yang, S. F. ,
Lee, C-T. ,
Ou, Y. C. ,
Lin, K. C. ,
Hu, C. Y. ,
Jou, Y. C. ,
Tsai, Y. S. &
Chow, N. H. ,
2023 8月 ,
於: Clinical Genitourinary Cancer. 21 ,
4 ,
p. 508.e1-508.e10 研究成果: Article › 同行評審
Urinary Tract
100%
Carcinoma
66%
Therapeutics
16%
Kidney Pelvis
13%
Ureter
11%
Hu, C. Y. ,
Wu, H. T. ,
Shan, Y. S. ,
Wang, C. T. ,
Shieh, G. S. ,
Wu, C. L. &
Ou, H. Y. ,
2023 4月 ,
於: International journal of molecular sciences. 24 ,
7 , 6021.
研究成果: Article › 同行評審
Lipid Peroxides
100%
Glutathione
84%
Evodiamine
78%
evodiamine
78%
Phospholipid Hydroperoxide Glutathione Peroxidase
74%
Liu, C. J. ,
Ho, K. T. ,
Tsai, Y. S. &
Huang, H. S. ,
2023 5月 ,
於: World Journal of Urology. 41 ,
5 ,
p. 1423-1430 8 p. 研究成果: Article › 同行評審
Calcium Oxalate Nephrolithiasis
100%
oxidized low density lipoprotein
61%
Urine
43%
Kidney
32%
Nephrolithiasis
31%
Ou, Y. C. ,
Kao, Y. L. ,
Ho, Y. H. ,
Wu, K. Y. &
Kuo, H. C. ,
2023 2月 ,
於: Toxins. 15 ,
2 , 95.
研究成果: Article › 同行評審
Intravesical
92%
Refractory
50%
Overactive Urinary Bladder
36%
Elderly
33%
Safety
27%
Liu, C-J. ,
Li, W. H. ,
Li, C. H. ,
Wu, J-S. ,
Lu, Z. H. ,
Tsai, Y-S. ,
Chao, T. H. &
Huang, H. S. ,
2023 7月 ,
於: World Journal of Urology. 41 ,
7 ,
p. 1967-1974 8 p. 研究成果: Article › 同行評審
Nephrolithiasis
100%
Coronary Stenosis
87%
Coronary Vessels
63%
Coronary Artery Disease
54%
Calcium
37%
Li, Y. T. ,
Tsai, Y. J. ,
Wang, L. Y. ,
Ou, Y. C. ,
Kao, Y. L. &
Lin, K. Y. ,
2023 1月 ,
於: Maturitas. 167 ,
p. 90-98 9 p. 研究成果: Article › 同行評審
Urinary Incontinence
100%
Randomized Controlled Trials
62%
Exercise
59%
Resistance
57%
Control Groups
37%
Cheng, Y. S. ,
Chen, H. Y. ,
Lin, Y. C. ,
Lin, Y. S. ,
Yeh, Y. C. ,
Yeh, Y. H. ,
Cheng, Y. H. ,
Lin, Y. M. ,
Weng, H. Y. ,
Lin, T. Y. &
Lin, S. C. ,
2023 10月 ,
於: Andrology. 11 ,
7 ,
p. 1286-1294 9 p. 研究成果: Article › 同行評審
Asthenozoospermia
100%
Spermatozoa
59%
Mitochondria
52%
Testis
17%
Spermatids
15%
Chen, W. A. ,
Huang, H. S. ,
Lu, Z. H. &
Liu, C-J. ,
2023 9月 ,
於: World Journal of Urology. 41 ,
9 ,
p. 2503-2509 7 p. 研究成果: Article › 同行評審
Percutaneous Nephrolithotomy
100%
Fever
55%
Hemorrhage
47%
ROC Curve
14%
Hemoglobins
13%
Lin, T. Y. ,
Su, C. C. ,
Chang, Y. C. ,
Chen, I. H. ,
Ou, C. H. &
Cheng, Y. S. ,
2023 2月 ,
於: International Journal of Urology. 30 ,
2 ,
p. 182-189 8 p. 研究成果: Article › 同行評審
Fournier Gangrene
100%
Delivery of Health Care
39%
Mortality
32%
Comorbidity
12%
Hospitalization
8%
Liu, C. M. ,
Liu, C. J. ,
Lu, Z. H. &
Huang, H. S. ,
2023 1月 ,
於: Diagnostics. 13 ,
2 , 247.
研究成果: Article › 同行評審
Brain Natriuretic Peptide
100%
Prohormone
88%
Hydronephrosis
67%
Recovery of Function
62%
Urine
40%
2022
diets
100%
Atorvastatin
93%
oxalates
84%
Calcium Oxalate
83%
Nutrition
79%
Varicocele
100%
Male Infertility
87%
Guidelines
49%
reproductive medicine
36%
management
36%
Tsai, Y. S. ,
Wu, T. Y. ,
Ou, C. H. ,
Cheng, H. L. ,
Tzai, T. S. ,
Yang, W. H. &
Wang, J. D. ,
2022 12月 ,
於: BMC Urology. 22 ,
1 , 126.
研究成果: Article › 同行評審
Cancer Survivors
97%
Urinary Bladder Neoplasms
85%
Quality of Life
57%
Muscles
53%
Sleep
25%
Lin, H. T. ,
Wu, M. H. ,
Wu, W. L. ,
Tsai, L. C. ,
Chen, Y. Y. ,
Hung, K. H. ,
Wu, P. H. ,
Chen, T. S. ,
Ou, H. T. &
Cheng, Y. S. ,
2022 5月 1 ,
於: Chinese Journal of Physiology. 65 ,
3 ,
p. 143-150 8 p. 研究成果: Article › 同行評審
Semen
100%
DNA Fragmentation
98%
Fertility
86%
Spermatozoa
85%
Chromatin
37%
Hu, C. Y. ,
Su, B. H. ,
Lee, Y. C. ,
Wang, C. T. ,
Yang, M. L. ,
Shen, W. T. ,
Fu, J. T. ,
Chen, S. Y. ,
Huang, W. Y. ,
Ou, C. H. ,
Tsai, Y. S. ,
Kuo, F. C. ,
Shiau, A. L. ,
Shieh, G. S. &
Wu, C. L. ,
2022 12月 ,
於: Journal of biomedical science. 29 ,
1 , 104.
研究成果: Article › 同行評審
Cachexia
100%
Long Noncoding RNA
88%
Urinary Bladder Neoplasms
78%
Cisplatin
70%
Drug Therapy
48%
Nephroureterectomy
100%
Urinary Tract
73%
Urinary Bladder
58%
Carcinoma
48%
Survival
20%
Kao, Y. L. ,
Ou, Y. C. ,
Tsai, K. J. &
Kuo, H. C. ,
2022 12月 ,
於: Toxins. 14 ,
12 , 877.
研究成果: Article › 同行評審
Underactive Urinary Bladder
99%
Toxin
88%
Refractory
72%
Injections
53%
Urinary Bladder
24%
Kidney Calculi
100%
Carotid Stenosis
93%
Cardiovascular Diseases
59%
Calcium
56%
Biomarkers
53%
Belladelli, F. ,
Chen, T. ,
Basran, S. ,
Greenberg, D. R. ,
Del Giudice, F. ,
Mulloy, E. ,
Chen, C. H. ,
Cheng, Y. S. ,
Salonia, A. &
Eisenberg, M. L. ,
2022 ,
於: World Journal of Men?s Health. 40 , 220106.
研究成果: Article › 同行評審
Asian Americans
100%
Semen
87%
Cannabis
85%
Semen Analysis
39%
Sperm Motility
19%
Jan, H. C. ,
Hu, C. Y. ,
Wu, K. Y. ,
Tai, T. Y. ,
Weng, H. Y. ,
Yang, W-H. &
Ou, C. H. ,
2022 ,
於: Cancer Management and Research. 14 ,
p. 3139-3149 11 p. 研究成果: Article › 同行評審
Nephroureterectomy
100%
Carcinoma
48%
Inflammation
43%
Survival
26%
ROC Curve
11%
Distal Kidney Tubule
100%
Lithotripsy
76%
Glutathione
57%
Dilatation
53%
Glutathione Transferase
45%
2021
Kao, Y. L. ,
Ou, C. H. ,
Lin, S. H. ,
Chang, S. M. ,
Wang, J. D. &
Tsai, Y. S. ,
2021 1月 1 ,
於: Journal of Clinical Medicine. 10 ,
1 ,
p. 1-10 10 p. , 158.
研究成果: Article › 同行評審
Prostatic Neoplasms
100%
Quality of Life
81%
Watchful Waiting
32%
Therapeutics
20%
Observation
19%
Lin, Y. C. ,
Jan, H. C. ,
Ou, H. Y. ,
Ou, C. H. &
Hu, C. Y. ,
2021 8月 2 ,
於: Journal of Clinical Medicine. 10 ,
16 , 3676.
研究成果: Article › 同行評審
Mean Platelet Volume
100%
Platelet Count
70%
Renal Cell Carcinoma
70%
Survival
16%
Disease Progression
9%
Lu, Z. H. ,
Lin, T. Y. ,
Huang, H. S. &
Liu, C. J. ,
2021 11月 ,
於: Urology Journal. 18 ,
6 ,
p. 600-607 8 p. 研究成果: Article › 同行評審
Percutaneous Nephrolithotomy
100%
Fever
55%
Urine
52%
Kidney
39%
Regression Analysis
12%
Weng, H. Y. ,
Lin, T. Y. ,
Lin, Y. M. &
Cheng, Y. S. ,
2021 11月 1 ,
於: Journal of the Chinese Medical Association. 84 ,
11 ,
p. 1023-1027 5 p. 研究成果: Article › 同行評審
Sperm Retrieval
100%
Fertility Preservation
89%
Decision Making
54%
Spermatozoa
24%
Parents
19%
Ou, Y. C. ,
Huang, K. H. ,
Jan, H. C. ,
Kuo, H. C. ,
Kao, Y. L. &
Tsai, K. J. ,
2021 ,
於: Toxins. 13 ,
6 , 398.
研究成果: Article › 同行評審
Botulinum Toxins
100%
Toxin
80%
Refractory
58%
Injections
48%
Urodynamics
24%
Wang, Y. W. ,
Song, H. L. ,
Chiang, C. Y. ,
Song, H. F. ,
Chang, H. Y. ,
Chu, C. A. ,
Tuan, Y. L. ,
Tsai, K. H. ,
Ou, Y. C. ,
Chow, N. H. &
Tsai, Y. S. ,
2021 10月 ,
於: Translational Oncology. 14 ,
10 , 101175.
研究成果: Article › 同行評審
Renal Cell Carcinoma
100%
Cell Line
61%
Erlotinib Hydrochloride
52%
ErbB Receptors
39%
Prostaglandin Receptors
29%
Lin, K. C. ,
Jan, H. C. ,
Hu, C. Y. ,
Ou, Y. C. ,
Kao, Y. L. ,
Yang, W. H. &
Ou, C. H. ,
2021 7月 1 ,
於: Journal of Clinical Medicine. 10 ,
13 , 2983.
研究成果: Article › 同行評審
Monocytes
100%
Necrosis
93%
Lymphocytes
83%
Carcinoma
79%
Neoplasms
38%
Cheng, H. L. ,
Chou, L. P. ,
Tsai, H. W. ,
Lee, C. T. ,
Wang, Y. W. ,
Chung-Liang, H. ,
Ou, J. H. ,
Tsai, Y. S. &
Chow, N. H. ,
2021 10月 ,
於: Urologic Oncology: Seminars and Original Investigations. 39 ,
10 ,
p. 732.e17-732.e23 研究成果: Article › 同行評審
Urinary Bladder
100%
Carcinoma
82%
Urinary Tract
50%
Urologic Neoplasms
35%
Statistical Models
28%
Lee, H. C. ,
Ou, C. H. ,
Huang, Y. C. ,
Hou, P. C. ,
Creighton, C. J. ,
Lin, Y. S. ,
Hu, C. Y. &
Lin, S. C. ,
2021 4月 1 ,
於: Oncogene. 40 ,
13 ,
p. 2407-2421 15 p. 研究成果: Article › 同行評審
MDV 3100
100%
Lipid Metabolism
65%
Prostatic Neoplasms
53%
Proteins
24%
Neoplasms
21%
2020
Jan, H. C. ,
Hu, C. Y. ,
Yang, W. H. &
Ou, C. H. ,
2020 8月 ,
於: Clinical Genitourinary Cancer. 18 ,
4 ,
p. e484-e500 研究成果: Article › 同行評審
Monocytes
100%
Blood Platelets
94%
Lymphocytes
83%
Carcinoma
79%
Neoplasms
38%
Huang, R. L. ,
Li, C. H. ,
Du, Y. F. ,
Cheng, K. P. ,
Lin, C. H. ,
Hu, C. Y. ,
Wu, J. S. ,
Chang, C-J. ,
Wu, H. T. &
Ou, H. Y. ,
2020 1月 1 ,
於: BioFactors. 46 ,
1 ,
p. 100-105 6 p. 研究成果: Article › 同行評審
Obesity
100%
Insulin Derivative
97%
Overweight
95%
Weight
76%
High-Density Lipoprotein Cholesterol
75%
Lai, C. H. ,
Huang, L. C. ,
Holby, S. N. ,
Lai, Y. J. ,
Su, P. F. ,
Cheng, Y. S. ,
Shyr, Y. &
Hsi, R. S. ,
2020 2月 ,
於: Urology. 136 ,
p. 75-81 7 p. 研究成果: Article › 同行評審
Kidney Calculi
100%
Hospital Mortality
33%
Myocardial Infarction
25%
Odds Ratio
22%
Propensity Score
12%
Urinary Calculi
100%
Kidney Calculi
95%
Dyslipidemias
76%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
76%
Biochemistry
70%
2019
Lin, Y. C. ,
Ou, C. H. ,
Yang, W. H. &
Kao, Y. L. ,
2019 11月 1 ,
於: Urological Science. 30 ,
6 ,
p. 250-254 5 p. 研究成果: Article › 同行評審
Urinary Bladder
100%
Cystoscopy
33%
aliflurane
19%
Nephroureterectomy
18%
Carcinoma
18%
Lin, T. Y. ,
Cheng, I. H. ,
Ou, C. H. ,
Tsai, Y. S. ,
Tong, Y. C. ,
Cheng, H. L. ,
Yang, W. H. ,
Lin, Y. M. &
Cheng, Y. S. ,
2019 7月 ,
於: International Journal of Urology. 26 ,
7 ,
p. 737-743 7 p. 研究成果: Article › 同行評審
Fournier Gangrene
100%
Survival
36%
Mortality
7%
Hospital Emergency Service
6%
Survivors
3%
Lin, C. C. ,
Cheng, K. P. ,
Hung, H. C. ,
Li, C. H. ,
Lin, C. H. ,
Chang, C. J. ,
Hu, C. Y. ,
Wu, H. T. &
Ou, H. Y. ,
2019 9月 ,
於: Journal of Clinical Medicine. 8 ,
9 , 1436.
研究成果: Article › 同行評審
secretogranin III
100%
Fasting
40%
Glucose
31%
Serum
22%
Endocrine Cells
10%
2018
Adenomatoid Tumor
100%
Epididymis
72%
Orchiectomy
36%
Scrotum
18%
Neoplasms
14%
Cheng, Y. Y. ,
Chang, Y. T. ,
Cheng, H. L. ,
Shen, K. H. ,
Sung, J. M. &
Guo, H. R. ,
2018 6月 1 ,
於: Science of the Total Environment. 626 ,
p. 581-591 11 p. 研究成果: Article › 同行評審
Arsenic
100%
Potable water
85%
Drinking Water
69%
arsenic
60%
drinking water
51%
Hu, C. Y. ,
Huang, C. Y. ,
Huang, K. H. ,
Tai, H. C. ,
Lin, Y. M. &
Tai, T. Y. ,
2018 1月 1 ,
於: Urological Science. 29 ,
1 ,
p. 33-37 5 p. 研究成果: Article › 同行評審
Nephroureterectomy
100%
Kidney Pelvis
60%
Hand
55%
Ureter
52%
Carcinoma
24%
Wu, T. T. L. ,
Tong, Y. C. ,
Chen, I. H. ,
Niu, H. S. ,
Li, Y. &
Cheng, J. T. ,
2018 ,
於: Oncotarget. 9 ,
13 ,
p. 11109-11118 10 p. 研究成果: Article › 同行評審
ginsenoside Rh2
100%
PPAR delta
87%
Prostatic Neoplasms
46%
Superoxides
29%
Reactive Oxygen Species
23%
Ou, Y. C. ,
Hu, C. Y. ,
Cheng, H. L. &
Yang, W. H. ,
2018 8月 31 ,
於: BMC Urology. 18 ,
1 , 73.
研究成果: Article › 同行評審
Ureteral Neoplasms
100%
Kidney
16%
Therapeutics
9%
Carcinoma
8%
Ureter
6%
Urinary Bladder
63%
Cannabinoid Receptor CB1
40%
Cannabinoid Receptor CB2
33%
AM 251
23%
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
21%
2017
Cheng, Y. S. ,
Lu, C. W. ,
Lin, T. Y. ,
Lin, P. Y. &
Lin, Y. M. ,
2017 7月 ,
於: Urology. 105 ,
p. 62-68 7 p. 研究成果: Article › 同行評審
Nonobstructive Azoospermia
100%
Sperm Retrieval
14%
Methylation
12%
Genetic Profile
6%
Messenger RNA
5%
Cheng, Y. S. ,
Chung, C. L. ,
Chen, C. F. &
Lin, Y. M. ,
2017 3月 1 ,
於: Urological Science. 28 ,
1 ,
p. 42-49 8 p. 研究成果: Article › 同行評審
Sertoli Cell-Only Syndrome
100%
Spermatogenesis
66%
MicroRNAs
51%
Microarray Analysis
15%
Reverse Transcription
6%
Hu, C. Y. ,
Wu, H. T. ,
Su, Y. C. ,
Lin, C. H. ,
Chang, C. J. &
Wu, C. L. ,
2017 7月 14 ,
於: Molecules (Basel, Switzerland). 22 ,
7 研究成果: Article › 同行評審
Evodiamine
100%
evodiamine
99%
cancer
54%
Hepatocellular Carcinoma
47%
mice
22%
Cheng, Y. S. ,
Wee, S. K. ,
Lin, T. Y. &
Lin, Y. M. ,
2017 12月 1 ,
於: Human Reproduction. 32 ,
12 ,
p. 2373-2381 9 p. 研究成果: Article › 同行評審
Methylation
68%
DNA Transposable Elements
32%
Spermatogenesis
27%
Germ Cells
24%
DNA Methylation
24%